Advanced Search
Contact | Corporate | Help

A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Sponsors:
  • H. Lee Moffitt Cancer Center and Research Institute
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Metastatic Pancreatic Carcinoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: gemcitabine, capecitabine, and erlotinib
Enrollment:
35

Additional information about NCT00480584.


SourceSolution © 2008-2012